Skip to main content
. 2017 Mar 24;21(10):2623–2626. doi: 10.1111/jcmm.13146

Figure 1.

Figure 1

Identification and characterization of the PROKR2 mutation. (A) Results of the molecular analyses. Black and white boxes in the genomic structure depict coding and non‐coding exons, respectively. The girl carried a heterozygous c.724_727delTGCT mutation in PROKR2 exon 2. RT‐PCR revealed the presence of both wild‐type (WT) and mutant mRNA. (B) Representative results of Ca2+ mobilization assays. The left panel shows Ca2+ flux curves of cells transfected with WT alone (blue lines), mutant alone (green lines), both wild‐type and mutant (WT + Mutant, purple lines), and an empty vector (red lines) (the mean ± 1.0 standard deviation). The cells were treated with 10−7 M PROK2 or buffer (Hank's balanced salt solution plus HEPES buffer). The right panel shows max Ca2+ responses to different doses of PROK2 (0, 10−9, 10−8 and 10−7 M) calculated from the ratio between the change in fluorescence signal intensity (Fmax‐F0) and the baseline intensity (F0). Asterisks indicate significant differences between WT alone and WT + Mutant (P ≤ 0.05).